Anthony J. Sinskey Ph.D., Sc.D.
Net Worth

Last updated:

What is Anthony J. Sinskey Ph.D., Sc.D. net worth?

The estimated net worth of Dr. Anthony J. Sinskey Ph.D., Sc.D. is at least $4,195,175 as of 17 Aug 2022. He owns shares worth $24,060 as insider, has earned $3,035,295 from insider trading and has received compensation worth at least $1,135,820 in Yield10 Bioscience, Inc..

What is the salary of Anthony J. Sinskey Ph.D., Sc.D.?

Dr. Anthony J. Sinskey Ph.D., Sc.D. salary is $59,780 per year as Co-Founder & Independent Director in Yield10 Bioscience, Inc..

How old is Anthony J. Sinskey Ph.D., Sc.D.?

Dr. Anthony J. Sinskey Ph.D., Sc.D. is 85 years old, born in 1940.

What stocks does Anthony J. Sinskey Ph.D., Sc.D. currently own?

As insider, Dr. Anthony J. Sinskey Ph.D., Sc.D. owns shares in one company:

Company Title Shares Price per share Total value
Yield10 Bioscience, Inc. (YTEN) Co-Founder & Independent Director 17,309 $1.39 $24,060

What does Yield10 Bioscience, Inc. do?

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Anthony J. Sinskey Ph.D., Sc.D. insider trading

Yield10 Bioscience, Inc.

Dr. Anthony J. Sinskey Ph.D., Sc.D. has made 16 insider trades between 2006-2022, according to the Form 4 filled with the SEC. Most recently he purchased 2,000 units of YTEN stock worth $5,600 on 17 Aug 2022.

The largest trade he's ever made was exercising 20,000 units of YTEN stock on 1 Mar 2010. As of 17 Aug 2022 he still owns at least 17,309 units of YTEN stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,000 $2.8 $5,600
Purchase
Common Stock 2,000 $2.85 $5,698
Purchase
Common Stock 2,000 $2.77 $5,530
Purchase
Common Stock 1,000 $6.23 $6,230
Purchase
Common Stock 2,000 $5.25 $10,500
Purchase
Common Stock 2,000 $4.89 $9,780
Purchase
Common Stock 2,000 $4.99 $9,980
Purchase
Common Stock 2,000 $4.33 $8,660
Purchase
Common Stock 2,000 $4.63 $9,256
Purchase
Common Stock 10,000 $1.92 $19,200
Purchase
Common Stock 10,000 $8.56 $85,620
Sale
Common Stock 20,000 $9.82 $196,480
Option
Stock Option (Right to Buy) 16,346 $1.65 $27,004
Option
Common Stock 16,346 $1.65 $27,004
Sale
Common Stock 15,801 $10.05 $158,784
Sale
Common Stock 15,801 $9.8 $154,834
Sale
Common Stock 15,801 $9.04 $142,857
Sale
Common Stock 4,400 $12 $52,800
Sale
Common Stock 10,600 $12 $127,232
Sale
Common Stock 10,000 $15.51 $155,130
Sale
Common Stock 10,000 $17.95 $179,510
Sale
Common Stock 9,689 $23.58 $228,428
Sale
Common Stock 10,000 $21.07 $210,720
Sale
Common Stock 10,000 $28.16 $281,630
Sale
Common Stock 10,000 $24.14 $241,400
Sale
Common Stock 10,000 $21.61 $216,070
Sale
Common Stock 10,000 $21.25 $212,490
Sale
Common Stock 10,000 $25 $250,000
Sale
Common Stock 10,000 $22.69 $226,930
Purchase
Common Stock 13,000 $14.3 $185,874

Yield10 Bioscience key executives

Yield10 Bioscience, Inc. executives and other stock owners filed with the SEC: